...
首页> 外文期刊>Prostaglandins, Leukotrienes, and Essential Fatty Acids >Changes of arterial arachidonic acid metabolites in hypertensive patients during haemodialysis.
【24h】

Changes of arterial arachidonic acid metabolites in hypertensive patients during haemodialysis.

机译:高血压患者血液透析过程中花生四烯酸代谢产物的变化。

获取原文
获取原文并翻译 | 示例

摘要

It is well known that in haemodialysis patients suffering from oligoanuria, extracellular hypervolaemia develops and this hypervolaemia is the main reason for hypertension occurring in some of the patients. The absence of vasorelaxation during hypervolaemia may be secondary to an increased activity of vasoconstrictor systems and/or a decreased formation of vasodilator agents like prostaglandin E2(PGE2) and prostaglandin I2(PGI2). In the present study, arterial PGE2 and leukotriene C4(LTC4)-like activities and the effect of fluid removal on these arachidonic acid metabolites during haemodialysis were measured in normotensive and hypertensive patients. Plasma PGE2 and LTC4-like activities were significantly different between hypertensive and normotensive patients. PGE2/LTC4 ratio did not change in normotensive patients while it was increased in hypertensive patients after haemodialysis. These results indicate that haemodialysis alters the synthesis of arachidonic acid metabolites especially in hypertensive patients.
机译:众所周知,在患有少尿尿症的血液透析患者中​​,发生细胞外高血容量,这种高血容量是某些患者发生高血压的主要原因。高容量血症期间不存在血管舒张可能是血管收缩系统活性增加和/或血管扩张剂如前列腺素E2(PGE2)和前列腺素I2(PGI2)形成减少所致。在本研究中,在血压正常和高血压患者中测量了动脉PGE2和白三烯C4(LTC4)样活性以及血液透析过程中液体清除对这些花生四烯酸代谢产物的影响。高血压患者和正常血压患者的血浆PGE2和LTC4样活性明显不同。在血压正常的患者中,PGE2 / LTC4的比例没有变化,而在血液透析后的高血压患者中,PGE2 / LTC4的比例却有所增加。这些结果表明血液透析改变了花生四烯酸代谢产物的合成,特别是在高血压患者中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号